Figure 2 | Scientific Reports

Figure 2

From: Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling

Figure 2

lncRNA validation in human samples. (A) The levels of top 3 lncRNAs were quantitated by quantitative RT-PCR in ovarian tumor samples from patients with diagnosed cisplatin resistance (n = 8). The levels shown are relative to levels in adjacent non-tumor tissue. (B) Levels of CHRF were evaluated in OC patients with liver metastasis (n = 6) by quantitative RT-PCR and compared to those in OC patients without liver metastasis (n = 6). *p < 0.01, relative to ‘no metastasis’.

Back to article page